Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 285 entries
Sorted by: Best Match Show Resources per page
Effect of adaptation to the task on solving the Group Embedded Figures Test

field instruction

Amador JA, Kirchner T.
GSID: Cnv0tbCmTeIJ
T Kirchner, M Forns, JA Amador - Perceptual and Motor …, 1989 - journals.sagepub.com

The often shown fact that the third series of the Group Embedded Figures Test has systematically been better solved than the second has led to the supposition of a possible …

Cite
Kirchner, T., Forns, M., & Amador, J. A. (1989). Effect of adaptation to the task on solving the Group Embedded Figures Test. Perceptual and Motor Skills, 68(3_suppl), 1303-1306.
Kirchner, Teresa, Maria Forns, and Juan Antonio Amador. "Effect of adaptation to the task on solving the Group Embedded Figures Test." Perceptual and Motor Skills 68.3_suppl (1989): 1303-1306.
Copy Download .nbib Format: MLA
Association between Attention and Heart Rate Fluctuations in Pathological Worriers.

Frontiers in human neuroscience

Gazzellini S, Dettori M, Amadori F, Paoli B, Napolitano A, Mancini F, Ottaviani C.
PMID: 28082881
Front Hum Neurosci. 2016 Dec 27;10:648. doi: 10.3389/fnhum.2016.00648. eCollection 2016.

Recent data suggests that several psychopathological conditions are associated with alterations in the variability of behavioral and physiological responses. Pathological worry, defined as the cognitive representation of a potential threat, has been associated with reduced variability of heart beat...

Cite
Gazzellini S, Dettori M, Amadori F, et al. Association between Attention and Heart Rate Fluctuations in Pathological Worriers. Front Hum Neurosci. 2016;10:648doi: 10.3389/fnhum.2016.00648.
Gazzellini, S., Dettori, M., Amadori, F., Paoli, B., Napolitano, A., Mancini, F., & Ottaviani, C. (2016). Association between Attention and Heart Rate Fluctuations in Pathological Worriers. Frontiers in human neuroscience, 10648. https://doi.org/10.3389/fnhum.2016.00648
Gazzellini, Simone, et al. "Association between Attention and Heart Rate Fluctuations in Pathological Worriers." Frontiers in human neuroscience vol. 10 (2016): 648. doi: https://doi.org/10.3389/fnhum.2016.00648
Gazzellini S, Dettori M, Amadori F, Paoli B, Napolitano A, Mancini F, Ottaviani C. Association between Attention and Heart Rate Fluctuations in Pathological Worriers. Front Hum Neurosci. 2016 Dec 27;10:648. doi: 10.3389/fnhum.2016.00648. eCollection 2016. PMID: 28082881; PMCID: PMC5187380.
Copy Download .nbib Format: NLM
Lorenzo Lotto's painting materials: an integrated diagnostic approach.

Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy

Amadori ML, Poldi G, Barcelli S, Baraldi P, Berzioli M, Casoli A, Marras S, Pojana G, Villa GC.
PMID: 27089184
Spectrochim Acta A Mol Biomol Spectrosc. 2016 Jul 05;164:110-22. doi: 10.1016/j.saa.2016.02.043. Epub 2016 Mar 31.

This paper presents the results of a comprehensive diagnostic investigation carried out on five paintings (three wood panels and two paintings on canvas) by Lorenzo Lotto, one of the most significant artists of the Italian Renaissance in the first...

Cite
Amadori ML, Poldi G, Barcelli S, et al. Lorenzo Lotto's painting materials: an integrated diagnostic approach. Spectrochim Acta A Mol Biomol Spectrosc. 2016;164:110-22doi: 10.1016/j.saa.2016.02.043.
Amadori, M. L., Poldi, G., Barcelli, S., Baraldi, P., Berzioli, M., Casoli, A., Marras, S., Pojana, G., & Villa, G. C. (2016). Lorenzo Lotto's painting materials: an integrated diagnostic approach. Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 164110-22. https://doi.org/10.1016/j.saa.2016.02.043
Amadori, Maria Letizia, et al. "Lorenzo Lotto's painting materials: an integrated diagnostic approach." Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy vol. 164 (2016): 110-22. doi: https://doi.org/10.1016/j.saa.2016.02.043
Amadori ML, Poldi G, Barcelli S, Baraldi P, Berzioli M, Casoli A, Marras S, Pojana G, Villa GC. Lorenzo Lotto's painting materials: an integrated diagnostic approach. Spectrochim Acta A Mol Biomol Spectrosc. 2016 Jul 05;164:110-22. doi: 10.1016/j.saa.2016.02.043. Epub 2016 Mar 31. PMID: 27089184.
Copy Download .nbib Format: NLM
Treatment of acute myeloid leukemia with 20-30% bone marrow blasts.

Mediterranean journal of hematology and infectious diseases

Maurillo L, Buccisano F, Del Principe MI, Sarlo C, Di Caprio L, Ditto C, Giannotti F, Nasso D, Ceresoli E, Postorino M, Refrigeri M, Amadori S, Venditti A.
PMID: 23795270
Mediterr J Hematol Infect Dis. 2013 Jun 03;5(1):e2013032. doi: 10.4084/MJHID.2013.032. Print 2013.

The transition of patients with ≥20% 30% BM blast. These controversies are even more manifest when it comes to elderly patients in whom concern for intensive chemotherapy (IC) related toxicity is the critical determinant for the therapeutic choice. In...

Cite
Maurillo L, Buccisano F, Del Principe MI, et al. Treatment of acute myeloid leukemia with 20-30% bone marrow blasts. Mediterr J Hematol Infect Dis. 2013;5(1):e2013032doi: 10.4084/MJHID.2013.032.
Maurillo, L., Buccisano, F., Del Principe, M. I., Sarlo, C., Di Caprio, L., Ditto, C., Giannotti, F., Nasso, D., Ceresoli, E., Postorino, M., Refrigeri, M., Amadori, S., & Venditti, A. (2013). Treatment of acute myeloid leukemia with 20-30% bone marrow blasts. Mediterranean journal of hematology and infectious diseases, 5(1), e2013032. https://doi.org/10.4084/MJHID.2013.032
Maurillo, Luca, et al. "Treatment of acute myeloid leukemia with 20-30% bone marrow blasts." Mediterranean journal of hematology and infectious diseases vol. 5,1 (2013): e2013032. doi: https://doi.org/10.4084/MJHID.2013.032
Maurillo L, Buccisano F, Del Principe MI, Sarlo C, Di Caprio L, Ditto C, Giannotti F, Nasso D, Ceresoli E, Postorino M, Refrigeri M, Amadori S, Venditti A. Treatment of acute myeloid leukemia with 20-30% bone marrow blasts. Mediterr J Hematol Infect Dis. 2013 Jun 03;5(1):e2013032. doi: 10.4084/MJHID.2013.032. Print 2013. PMID: 23795270; PMCID: PMC3684350.
Copy Download .nbib Format: NLM
Management of complication after breast augmentation with methacrylate.

International journal of surgery case reports

Grella R, Almadori A, D'Ari A, Romanucci V, D'Andrea F.
PMID: 26298244
Int J Surg Case Rep. 2015;15:17-20. doi: 10.1016/j.ijscr.2015.06.038. Epub 2015 Jul 10.

INTRODUCTION: Several alloplastic biomaterials are available for injection to the breast, nevertheless not all of them are approved for biomedical use. Although in North America and Western Europe experience with synthetic biomaterials for breast augmentation is very limited, migratory...

Cite
Grella R, Almadori A, D'Ari A, et al. Management of complication after breast augmentation with methacrylate. Int J Surg Case Rep. 2015;15:17-20doi: 10.1016/j.ijscr.2015.06.038.
Grella, R., Almadori, A., D'Ari, A., Romanucci, V., & D'Andrea, F. (2015). Management of complication after breast augmentation with methacrylate. International journal of surgery case reports, 1517-20. https://doi.org/10.1016/j.ijscr.2015.06.038
Grella, Roberto, et al. "Management of complication after breast augmentation with methacrylate." International journal of surgery case reports vol. 15 (2015): 17-20. doi: https://doi.org/10.1016/j.ijscr.2015.06.038
Grella R, Almadori A, D'Ari A, Romanucci V, D'Andrea F. Management of complication after breast augmentation with methacrylate. Int J Surg Case Rep. 2015;15:17-20. doi: 10.1016/j.ijscr.2015.06.038. Epub 2015 Jul 10. PMID: 26298244; PMCID: PMC4601943.
Copy Download .nbib Format: NLM
Impaired NGF/TrkA Signaling Causes Early AD-Linked Presynaptic Dysfunction in Cholinergic Primary Neurons.

Frontiers in cellular neuroscience

Latina V, Caioli S, Zona C, Ciotti MT, Amadoro G, Calissano P.
PMID: 28360840
Front Cell Neurosci. 2017 Mar 15;11:68. doi: 10.3389/fncel.2017.00068. eCollection 2017.

Alterations in NGF/TrkA signaling have been suggested to underlie the selective degeneration of the cholinergic basal forebrain neurons occurring

Cite
Latina V, Caioli S, Zona C, et al. Impaired NGF/TrkA Signaling Causes Early AD-Linked Presynaptic Dysfunction in Cholinergic Primary Neurons. Front Cell Neurosci. 2017;11:68doi: 10.3389/fncel.2017.00068.
Latina, V., Caioli, S., Zona, C., Ciotti, M. T., Amadoro, G., & Calissano, P. (2017). Impaired NGF/TrkA Signaling Causes Early AD-Linked Presynaptic Dysfunction in Cholinergic Primary Neurons. Frontiers in cellular neuroscience, 1168. https://doi.org/10.3389/fncel.2017.00068
Latina, Valentina, et al. "Impaired NGF/TrkA Signaling Causes Early AD-Linked Presynaptic Dysfunction in Cholinergic Primary Neurons." Frontiers in cellular neuroscience vol. 11 (2017): 68. doi: https://doi.org/10.3389/fncel.2017.00068
Latina V, Caioli S, Zona C, Ciotti MT, Amadoro G, Calissano P. Impaired NGF/TrkA Signaling Causes Early AD-Linked Presynaptic Dysfunction in Cholinergic Primary Neurons. Front Cell Neurosci. 2017 Mar 15;11:68. doi: 10.3389/fncel.2017.00068. eCollection 2017. PMID: 28360840; PMCID: PMC5350152.
Copy Download .nbib Format: NLM
Phase II Study of Bortezomib as a Single Agent in Patients with Previously Untreated or Relapsed/Refractory Acute Myeloid Leukemia Ineligible for Intensive Therapy.

Leukemia research and treatment

Sarlo C, Buccisano F, Maurillo L, Cefalo M, Di Caprio L, Cicconi L, Ditto C, Ottaviani L, Di Veroli A, Del Principe MI, Grasso MA, Nasso D, De Santis G, Amadori S, Venditti A.
PMID: 23738080
Leuk Res Treatment. 2013;2013:705714. doi: 10.1155/2013/705714. Epub 2013 Apr 28.

We explored the safety and efficacy of bortezomib given as single agent in patients with untreated or relapsed/refractory acute myeloid leukemia (AML), unfit for conventional chemotherapy. Fourteen patients were treated with bortezomib 1.5 mg/m(2) administered twice weekly for two...

Cite
Sarlo C, Buccisano F, Maurillo L, et al. Phase II Study of Bortezomib as a Single Agent in Patients with Previously Untreated or Relapsed/Refractory Acute Myeloid Leukemia Ineligible for Intensive Therapy. Leuk Res Treatment. 2013;2013:705714doi: 10.1155/2013/705714.
Sarlo, C., Buccisano, F., Maurillo, L., Cefalo, M., Di Caprio, L., Cicconi, L., Ditto, C., Ottaviani, L., Di Veroli, A., Del Principe, M. I., Grasso, M. A., Nasso, D., De Santis, G., Amadori, S., & Venditti, A. (2013). Phase II Study of Bortezomib as a Single Agent in Patients with Previously Untreated or Relapsed/Refractory Acute Myeloid Leukemia Ineligible for Intensive Therapy. Leukemia research and treatment, 2013705714. https://doi.org/10.1155/2013/705714
Sarlo, Chiara, et al. "Phase II Study of Bortezomib as a Single Agent in Patients with Previously Untreated or Relapsed/Refractory Acute Myeloid Leukemia Ineligible for Intensive Therapy." Leukemia research and treatment vol. 2013 (2013): 705714. doi: https://doi.org/10.1155/2013/705714
Sarlo C, Buccisano F, Maurillo L, Cefalo M, Di Caprio L, Cicconi L, Ditto C, Ottaviani L, Di Veroli A, Del Principe MI, Grasso MA, Nasso D, De Santis G, Amadori S, Venditti A. Phase II Study of Bortezomib as a Single Agent in Patients with Previously Untreated or Relapsed/Refractory Acute Myeloid Leukemia Ineligible for Intensive Therapy. Leuk Res Treatment. 2013;2013:705714. doi: 10.1155/2013/705714. Epub 2013 Apr 28. PMID: 23738080; PMCID: PMC3655652.
Copy Download .nbib Format: NLM
The current role of telomerase in the diagnosis of bladder cancer.

Indian journal of urology : IJU : journal of the Urological Society of India

Bravaccini S, Casadio V, Amadori D, Calistri D, Silvestrini R.
PMID: 19468427
Indian J Urol. 2009 Jan;25(1):40-6. doi: 10.4103/0970-1591.45535.

Bladder cancer has an incidence of 15 cases per 100,000 persons in the global population and is the most common tumor of the urinary tract. Imaging techniques, cytoscopy, and cytology are either invasive or not sufficiently accurate to detect...

Cite
Bravaccini S, Casadio V, Amadori D, et al. The current role of telomerase in the diagnosis of bladder cancer. Indian J Urol. 2009;25(1):40-6doi: 10.4103/0970-1591.45535.
Bravaccini, S., Casadio, V., Amadori, D., Calistri, D., & Silvestrini, R. (2009). The current role of telomerase in the diagnosis of bladder cancer. Indian journal of urology : IJU : journal of the Urological Society of India, 25(1), 40-6. https://doi.org/10.4103/0970-1591.45535
Bravaccini, Sara, et al. "The current role of telomerase in the diagnosis of bladder cancer." Indian journal of urology : IJU : journal of the Urological Society of India vol. 25,1 (2009): 40-6. doi: https://doi.org/10.4103/0970-1591.45535
Bravaccini S, Casadio V, Amadori D, Calistri D, Silvestrini R. The current role of telomerase in the diagnosis of bladder cancer. Indian J Urol. 2009 Jan;25(1):40-6. doi: 10.4103/0970-1591.45535. PMID: 19468427; PMCID: PMC2684324.
Copy Download .nbib Format: NLM
Hyperlalia: a right cerebral hemisphere syndrome.

Behavioural neurology

Yamadori A, Osumi Y, Tabuchi M, Mori E, Yoshida T, Ohkawa S, Yoneda Y.
PMID: 24487238
Behav Neurol. 1990;3(3):143-51. doi: 10.3233/BEN-1990-3302.

We describe a new right hemispheric behavioural syndrome for which we propose the name "hyperlalia". In a typical case an apparently unconcerned and expressionless patient is easily prompted to remarkable volubility with a content which is loose and incoherent....

Cite
Yamadori A, Osumi Y, Tabuchi M, et al. Hyperlalia: a right cerebral hemisphere syndrome. Behav Neurol. 1990;3(3):143-51doi: 10.3233/BEN-1990-3302.
Yamadori, A., Osumi, Y., Tabuchi, M., Mori, E., Yoshida, T., Ohkawa, S., & Yoneda, Y. (1990). Hyperlalia: a right cerebral hemisphere syndrome. Behavioural neurology, 3(3), 143-51. https://doi.org/10.3233/BEN-1990-3302
Yamadori, A, et al. "Hyperlalia: a right cerebral hemisphere syndrome." Behavioural neurology vol. 3,3 (1990): 143-51. doi: https://doi.org/10.3233/BEN-1990-3302
Yamadori A, Osumi Y, Tabuchi M, Mori E, Yoshida T, Ohkawa S, Yoneda Y. Hyperlalia: a right cerebral hemisphere syndrome. Behav Neurol. 1990;3(3):143-51. doi: 10.3233/BEN-1990-3302. PMID: 24487238.
Copy Download .nbib Format: NLM
Safety and Efficacy of Sorafenib in Patients with Hepatocellular Carcinoma (HCC) and Child-Pugh A versus B Cirrhosis.

Gastrointestinal cancer research : GCR

Abou-Alfa GK, Amadori D, Santoro A, Figer A, De Greve J, Lathia C, Voliotis D, Anderson S, Moscovici M, Ricci S.
PMID: 21673874
Gastrointest Cancer Res. 2011 Mar;4(2):40-4.

BACKGROUND: We performed a retrospective analysis of data from a phase II study evaluating sorafenib in patients with advanced hepatocellular carcinoma (HCC) to assess differences in safety and efficacy based on Child-Pugh (CP) status (A/B).METHODS: Patients received sorafenib 400...

Cite
Abou-Alfa GK, Amadori D, Santoro A, et al. Safety and Efficacy of Sorafenib in Patients with Hepatocellular Carcinoma (HCC) and Child-Pugh A versus B Cirrhosis. Gastrointest Cancer Res. 2011;4(2):40-4
Abou-Alfa, G. K., Amadori, D., Santoro, A., Figer, A., De Greve, J., Lathia, C., Voliotis, D., Anderson, S., Moscovici, M., & Ricci, S. (2011). Safety and Efficacy of Sorafenib in Patients with Hepatocellular Carcinoma (HCC) and Child-Pugh A versus B Cirrhosis. Gastrointestinal cancer research : GCR, 4(2), 40-4.
Abou-Alfa, Ghassan K, et al. "Safety and Efficacy of Sorafenib in Patients with Hepatocellular Carcinoma (HCC) and Child-Pugh A versus B Cirrhosis." Gastrointestinal cancer research : GCR vol. 4,2 (2011): 40-4.
Abou-Alfa GK, Amadori D, Santoro A, Figer A, De Greve J, Lathia C, Voliotis D, Anderson S, Moscovici M, Ricci S. Safety and Efficacy of Sorafenib in Patients with Hepatocellular Carcinoma (HCC) and Child-Pugh A versus B Cirrhosis. Gastrointest Cancer Res. 2011 Mar;4(2):40-4. PMID: 21673874; PMCID: PMC3109886.
Copy Download .nbib Format: NLM
Recurrence of a t(8;21)-Positive Acute Myeloid Leukemia in the Form of a Granulocytic Sarcoma Involving Cranial Bones: A Diagnostic and Therapeutic Challenge.

Case reports in hematology

Di Veroli A, Micarelli A, Cefalo M, Ceresoli E, Nasso D, Cicconi L, Mauramati S, Ottaviani F, Venditti A, Amadori S.
PMID: 24109526
Case Rep Hematol. 2013;2013:245395. doi: 10.1155/2013/245395. Epub 2013 Sep 12.

Granulocytic sarcoma (GS) is a rare extramedullary solid tumor defined as an accumulation of myeloblasts or immature myeloid cells. It can cooccur with or precede the acute myeloid leukemia (AML) as well as following treated AML. The incidence of...

Cite
Di Veroli A, Micarelli A, Cefalo M, et al. Recurrence of a t(8;21)-Positive Acute Myeloid Leukemia in the Form of a Granulocytic Sarcoma Involving Cranial Bones: A Diagnostic and Therapeutic Challenge. Case Rep Hematol. 2013;2013:245395doi: 10.1155/2013/245395.
Di Veroli, A., Micarelli, A., Cefalo, M., Ceresoli, E., Nasso, D., Cicconi, L., Mauramati, S., Ottaviani, F., Venditti, A., & Amadori, S. (2013). Recurrence of a t(8;21)-Positive Acute Myeloid Leukemia in the Form of a Granulocytic Sarcoma Involving Cranial Bones: A Diagnostic and Therapeutic Challenge. Case reports in hematology, 2013245395. https://doi.org/10.1155/2013/245395
Di Veroli, Ambra, et al. "Recurrence of a t(8;21)-Positive Acute Myeloid Leukemia in the Form of a Granulocytic Sarcoma Involving Cranial Bones: A Diagnostic and Therapeutic Challenge." Case reports in hematology vol. 2013 (2013): 245395. doi: https://doi.org/10.1155/2013/245395
Di Veroli A, Micarelli A, Cefalo M, Ceresoli E, Nasso D, Cicconi L, Mauramati S, Ottaviani F, Venditti A, Amadori S. Recurrence of a t(8;21)-Positive Acute Myeloid Leukemia in the Form of a Granulocytic Sarcoma Involving Cranial Bones: A Diagnostic and Therapeutic Challenge. Case Rep Hematol. 2013;2013:245395. doi: 10.1155/2013/245395. Epub 2013 Sep 12. PMID: 24109526; PMCID: PMC3787645.
Copy Download .nbib Format: NLM
P62 deficiency shifts mesenchymal/stromal stem cell commitment toward adipogenesis and disrupts bone marrow homeostasis in aged mice.

Journal of cellular physiology

Lacava G, Laus F, Amaroli A, Marchegiani A, Censi R, Di Martino P, Yanagawa T, Sabbieti MG, Agas D.
PMID: 30740681
J Cell Physiol. 2019 Feb 10; doi: 10.1002/jcp.28299. Epub 2019 Feb 10.

With advancing age have been observed bone and bone marrow phenotypic alterations due to the impaired bone tissue homeostatic features, involving bone remodeling, and bone marrow niche ontogeny. The complex "inflamm-aging" pathological scenario that culminates with osteopenia and mesenchymal/stromal...

Cite
Lacava G, Laus F, Amaroli A, et al. P62 deficiency shifts mesenchymal/stromal stem cell commitment toward adipogenesis and disrupts bone marrow homeostasis in aged mice. J Cell Physiol. 2019;doi: 10.1002/jcp.28299.
Lacava, G., Laus, F., Amaroli, A., Marchegiani, A., Censi, R., Di Martino, P., Yanagawa, T., Sabbieti, M. G., & Agas, D. (2019). P62 deficiency shifts mesenchymal/stromal stem cell commitment toward adipogenesis and disrupts bone marrow homeostasis in aged mice. Journal of cellular physiology, . https://doi.org/10.1002/jcp.28299
Lacava, Giovanna, et al. "P62 deficiency shifts mesenchymal/stromal stem cell commitment toward adipogenesis and disrupts bone marrow homeostasis in aged mice." Journal of cellular physiology vol. (2019). doi: https://doi.org/10.1002/jcp.28299
Lacava G, Laus F, Amaroli A, Marchegiani A, Censi R, Di Martino P, Yanagawa T, Sabbieti MG, Agas D. P62 deficiency shifts mesenchymal/stromal stem cell commitment toward adipogenesis and disrupts bone marrow homeostasis in aged mice. J Cell Physiol. 2019 Feb 10; doi: 10.1002/jcp.28299. Epub 2019 Feb 10. PMID: 30740681.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 285 entries